通过糖酵解和脂解作用的调节维持乳酸稳态

Lactate homeostasis is maintained through regulation of glycolysis and lipolysis

作者信息Won Dong Lee, Daniel R Weilandt, Lingfan Liang, Michael R MacArthur, Natasha Jaiswal, Olivia Ong, Charlotte G Mann, Qingwei Chu, Craig J Hunter, Rolf-Peter Ryseck, Wenyun Lu, Anna M Oschmann, Alexis J Cowan, Tara A TeSlaa, Caroline R Bartman, Cholsoon Jang, Joseph A Baur, Paul M Titchenell, Joshua D Rabinowitz
PMID39889702
发布时间2025-03-04
DOI10.1016/j.cmet.2024.12.009

实验完整度

涉及小鼠体内代谢实验、稳定同位素示踪、基因敲除模型、离体肌纤维实验和数学模型,包含功能验证和机制验证。

主要模型

C57BL/6N小鼠 HCAR1基因敲除小鼠 小鼠离体肌纤维

重点核对

胰岛素输注剂量:1.25或2.5 mU min−1 (kg body weight)−1 乳酸输注剂量:130 nmol min−1 (g body weight)−1 HCAR1激动剂剂量:100 mg (kg body weight)−1 离体肌纤维乳酸浓度:20 mM,胰岛素浓度:10 nM 高胰岛素-正葡萄糖钳夹技术

摘要

Lactate is among the highest flux circulating metabolites. It is made by glycolysis and cleared by both tricarboxylic acid (TCA) cycle oxidation and gluconeogenesis. Severe lactate elevations are life-threatening, and modest elevations predict future diabetes. How lactate homeostasis is maintained, however, remains poorly understood. Here, we identify, in mice, homeostatic circuits regulating lactate production and consumption. Insulin induces lactate production by upregulating glycolysis. We find that hyperlactatemia inhibits insulin-induced glycolysis, thereby suppressing excess lactate production. Unexpectedly, insulin also promotes lactate TCA cycle oxidation. The mechanism involves lowering circulating fatty acids, which compete with lactate for mitochondrial oxidation. Similarly, lactate can promote its own consumption by lowering circulating fatty acids via the adipocyte-expressed G-protein-coupled receptor hydroxycarboxylic acid receptor 1 (HCAR1). Quantitative modeling suggests that these mechanisms suffice to produce lactate homeostasis, with robustness to noise and perturbation of individual regulatory mechanisms. Thus, through regulation of glycolysis and lipolysis, lactate homeostasis is maintained.

实验结论

提炼研究问题、关键发现与证据,快速把握文章的核心贡献。

研究问题
哺乳动物体内乳酸稳态是如何维持的?
核心机制
胰岛素通过上调糖酵解促进乳酸生成,同时通过抑制脂肪组织脂解降低循环脂肪酸水平,从而促进乳酸在线粒体TCA循环中的氧化;乳酸通过HCAR1抑制脂解,并通过抑制肌肉胰岛素信号反馈抑制自身生成。
主要证据
小鼠体内实验显示胰岛素升高乳酸生成和氧化,脂肪酸下降促进乳酸氧化;HCAR1敲除和激动剂实验证实乳酸通过HCAR1抑制脂解;离体肌纤维实验显示乳酸阻断胰岛素诱导的GLUT4转位;定量模型模拟了乳酸稳态的鲁棒性。
研究意义
揭示了乳酸稳态的调节机制,为理解代谢疾病中的乳酸失调提供了理论基础,并提示定量模型在系统代谢研究中的应用潜力。

研究路径

按研究推进顺序梳理实验设计、验证步骤与关键观察。

1

胰岛素对乳酸代谢的影响

评估胰岛素对乳酸生成和消耗的影响

对禁食小鼠注射胰岛素或进行高胰岛素-正葡萄糖钳夹,结合13C-乳酸示踪检测乳酸浓度、生成和氧化通量。

2

脂肪酸对乳酸氧化的竞争作用

验证脂肪酸是否与乳酸竞争性氧化

在胰岛素钳夹期间输注脂肪乳剂(Intralipid)以恢复脂肪酸水平,检测乳酸氧化通量变化。

3

HCAR1介导的乳酸对脂解的抑制

验证乳酸通过HCAR1抑制脂肪分解从而促进乳酸消耗

对HCAR1敲除和野生型小鼠输注乳酸或注射HCAR1激动剂,检测循环脂肪酸水平和乳酸氧化。

4

乳酸对胰岛素信号的反馈抑制

验证乳酸是否通过抑制肌肉胰岛素信号来减少自身生成

在胰岛素钳夹期间输注乳酸,检测葡萄糖处置、乳酸生成、肌肉胰岛素信号通路和GLUT4转位。

5

定量建模验证乳酸稳态的鲁棒性

整合实验发现的调节机制,构建数学模型并测试其稳定性

建立葡萄糖-乳酸-脂肪酸-胰岛素的动态模型,模拟胰岛素注射和钳夹反应,并评估参数扰动和基因敲除的影响。

研究方法

按研究目的归类文中使用的方法,便于定位所需技术。

产品清单

实验环节名称品牌货号
C57BL/6N小鼠Charles River LaboratoriesC57BL/6
HCAR1基因敲除小鼠--HCAR1 KO
优泌林REli LillyCat#R U-100
英脱利匹特SigmaCat#I141
HCAR1激动剂HY-135982MedChemExpressHY-135982
罗氏血糖仪RocheCat#06351557018
乳酸仪Nova BiomedicalCat#ALP10110
游离脂肪酸检测试剂盒Abcamab65341
超敏小鼠胰岛素ELISA试剂盒Crystal Chem90080
Vanquish Horizon超高效液相色谱系统Thermo Scientific--
Orbitrap Exploris 480质谱仪Thermo Scientific--
Q Exactive Plus质谱仪Thermo Scientific--
XBridge BEH Amide XP色谱柱Waters--
Poroshell 120 EC-C18色谱柱Agilent--
冷冻研磨仪Retsch--
pLenti-myc-GLUT4-mCherry质粒Addgene64049
Lipofectamine 3000转染试剂InvitrogenL3000015
Pierce BCA蛋白测定试剂盒Thermo Fisher--
抗磷酸化胰岛素受体抗体Cell Signaling Technology3024
抗磷酸化PI3K p85抗体Cell Signaling Technology4228
抗磷酸化Akt抗体Cell Signaling Technology4060
抗Akt抗体Cell Signaling Technology4691
抗磷酸化S6抗体Cell Signaling Technology4858
抗Vinculin抗体Cell Signaling Technology13901
山羊抗兔IgG HRP标记二抗MilliporeSigma12348
2-脱氧-D-[1-13C]葡萄糖Cambridge Isotope Laboratories--
L-[U-13C]乳酸钠Cambridge Isotope LaboratoriesCLM-1579
D-葡萄糖(U-13C6, 99%)Cambridge Isotope LaboratoriesCLM-1396
L-丙氨酸(13C3, 99%; 15N, 99%)Cambridge Isotope LaboratoriesCNLM-534
L-谷氨酰胺(13C5, 99%; 15N2, 99%)Cambridge Isotope LaboratoriesCNLM-1275
甘油(13C3, 99%)Cambridge Isotope LaboratoriesCLM-1510
亚油酸(U-13C18, 98%)Cambridge Isotope LaboratoriesCLM-8835
油酸钠盐(U-13C18, 98%)Cambridge Isotope LaboratoriesCLM-8763
棕榈酸钠(U-13C16, 98%+)Cambridge Isotope LaboratoriesCLM-6059
DMEM培养基----
Myc标签兔单克隆抗体Cell Signaling Technology2278
Alexa Fluor 488抗兔二抗InvitrogenA11034
ProteoWizard软件----
El-MAVEN软件----
AccuCor2软件----
GraphPad Prism软件----
Promethion间接测热仪Sable Systems International--

关键环节

汇总复现实验时建议重点确认的条件及原文阅读提示。

环节核对要点
动物实验
小鼠品系:C57BL/6N,年龄10-14周,雄性;饲养环境:温度、光照周期、饮食
阅读提示:STAR METHODS - Animals
胰岛素注射
胰岛素剂量:0.5或0.1 U (kg body weight)−1;给药途径:静脉注射
阅读提示:STAR METHODS - Insulin tolerance test
高胰岛素-正葡萄糖钳夹
胰岛素输注速率:1.25或2.5 mU min−1 (kg body weight)−1;葡萄糖输注以维持血糖120-130 mg/dL
阅读提示:STAR METHODS - Hyperinsulinemic-euglycemic clamp
乳酸输注
乳酸输注速率:130 nmol min−1 (g body weight)−1;使用5% (w/w) sodium-L-lactate
阅读提示:STAR METHODS - Hyperinsulinemic-euglycemic clamp
HCAR1激动剂注射
HCAR1激动剂剂量:100 mg (kg body weight)−1;给药途径:腹腔注射
阅读提示:STAR METHODS - HCAR1 (GPR81) agonist injection
离体肌纤维实验
肌纤维来源:FDB肌肉;乳酸浓度:20 mM;丙酮酸盐浓度:2 mM;胰岛素浓度:10 nM;预处理时间:15分钟
阅读提示:STAR METHODS - Ex vivo GLUT4 translocation assay